Safe Harbor Statement
This press release includes forward-looking statements regarding the
development, therapeutic potential, efficacy and safety of AZ-004. Any
statement describing a product candidate or Alexza's goals, expectations or
beliefs is a forward-looking statement, as defined in the Private Securities
Litigation Reform Act of 1995, and should be considered an at-risk statement.
Such statements are subject to certain risks and uncertainties, particularly
those inherent in the process of developing and commercializing drugs. The
Company's forward-looking statements also involve assumptions that, if they
prove incorrect, would cause its results to differ materially from those
expressed or implied by such forward-looking statements. These and other
risks concerning Alexza's business are described in additional detail in the
Company's Annual Report on Form 10-K for the year ended December 31, 2007, and
the Company's other Periodic and Current Reports filed with the Securities and
Exchange Commission including the risks under the heading: "We will need
substantial additional capital in the future. If additional capital is not
available, we will have to delay, reduce or cease operations".
|SOURCE Alexza Pharmaceuticals, Inc.|
Copyright©2009 PR Newswire.
All rights reserved